Using machine learning to predict blood culture outcomes in the emergency department: a single-centre, retrospective, observational study.
Anneroos W Boerman, Michiel Schinkel, Lotta Meijerink...
https://pubmed.ncbi.nlm.nih.gov/34983764Actively Recruiting
Led by Amsterdam UMC, location VUmc · Updated on 2024-05-07
7584
Participants Needed
1
Research Sites
25 weeks
Total Duration
This research aims to evaluate whether using a blood culture prediction tool based on machine learning is as effective as current practices for adult patients in the emergency department who need a blood culture analysis. The study focuses on patients who have a clinical indication for blood cultures as determined by their treating physician. The primary goal is to compare 30-day mortality rates, with additional outcomes including hospital admission rates, in-hospital mortality, and length of hospital stay. Participants will be randomly assigned to one of two groups. In the intervention group, doctors will use the blood culture prediction tool to decide whether to perform the blood culture test; if the predicted chance of a positive result is less than 5%, the test will be cancelled. In the control group, all patients will undergo blood culture analysis as usual. This randomized controlled trial aims to see if the prediction tool can reduce unnecessary blood cultures and associated issues without increasing risks. During the study, patients will be monitored for 30 days to assess mortality, with hospital admission, in-hospital mortality, and length of stay tracked up to 90 days. Data such as laboratory results and vital signs are collected to support predictions. Safety and outcomes will be carefully reviewed to determine if the tool offers a non-inferior approach compared to standard blood culture testing. Participation duration and follow-up will be based on these timelines to capture relevant clinical outcomes.
CONDITIONS
Appropriate Use of Blood Cultures in the Emergency Department Through Machine Learning
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to 30 days
Participants undergo blood culture analysis based on either a machine learning prediction tool or the treating physician's decision.
1 visit (in-person) at the emergency department
Duration - Up to 90 days
Participants are monitored for outcomes including mortality, hospital admission, and length of stay following the blood culture analysis.
Follow-up assessments during hospital stay and up to 90 days after initial visit
Total: 1 location
1
Amsterdam UMC - location AMC
Amsterdam, Netherlands
Actively Recruiting
P
Prabath WB Nanayakkara, MD, PhD
S
Sheena C Bhagirath, MD
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Anneroos W Boerman, Michiel Schinkel, Lotta Meijerink...
https://pubmed.ncbi.nlm.nih.gov/34983764Michiel Schinkel, Anneroos W Boerman, Frank C Bennis...
https://pubmed.ncbi.nlm.nih.gov/35853298Anuschka Y van der Zaag, Sheena C Bhagirath, Anneroos W Boerman...
https://pubmed.ncbi.nlm.nih.gov/38821574